Laparoscopic ureterocystoplasty with Mitrofanoff system.

Area of Science:

• Urology
• Pediatric Surgery
• Minimally Invasive Surgery

Background:

• Neurogenic bladder, often associated with myelomeningocele, presents challenges in bladder management, including low capacity and high bladder leak point pressure (BLPP).
• Traditional augmentation cystoplasty, such as enterocystoplasty, carries significant morbidity.
• The Mitrofanoff procedure creates a continent urinary diversion, but bladder augmentation is often necessary.

Purpose of the Study:

• To describe a laparoscopic surgical technique for ureterocystoplasty in pediatric patients undergoing the Mitrofanoff procedure.
• To evaluate the efficacy and safety of this technique in augmenting bladder capacity and improving urodynamic parameters.

Main Methods:

• The study involved 4 pediatric patients (8-11 years) with myelomeningocele and neurogenic bladder.
• Laparoscopic ureterocystoplasty augmentation and Mitrofanoff creation using the proximal ureter were performed.
• Pre- and postoperative urodynamic assessments, renal ultrasound, voiding cystourethrography, and renal scintigraphy were utilized.

Main Results:

• Follow-up of 2-4 years demonstrated restored bladder capacity (≥75% age-appropriate), improved compliance (15-20 mL/cm H2O), and reduced BLPP (<40 cm H2O).
• The reduced BLPP indicates a lower risk of upper urinary tract damage.
• No stomal leakage was observed during 4-hour catheterization periods.

Conclusions:

• Laparoscopic ureterocystoplasty is a potentially effective alternative to enterocystoplasty for neurogenic bladder augmentation.
• This technique is particularly suitable for patients with specific conditions like pop-off phenomenon and ipsilateral renal atrophy.
• The laparoscopic approach offers a minimally invasive option with reduced morbidity compared to open procedures.